CID Holdco receives Nasdaq deficiency notices for bid price, MVLS, MVPHS; executives loan $208k

CID Holdco, Inc.

Nasdaq notified CID Holdco of minimum bid price ($1) and MVLS ($50M) deficiencies on Feb 5, 2026.
A third notice on Feb 10, 2026 cited MVPHS deficiency ($15M); compliance deadline Aug 4/10, 2026.
Company may request Nasdaq Capital Market transfer if bid price not cured within 180-day period.
CEO, CFO, CTO loaned $208,000 (7.5% interest, unsecured) on Feb 6, 2026; up to $600,000 total.
Executive loans subordinated to J.J. Astor & Co. obligations; repayment starts July 1, 2026.

item 1.01 item 2.03 item 3.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-014914
form_type: 8-K
ticker: DAIC
cik: 0002033770
company_name: CID Holdco, Inc.
filed_at: 2026-02-11T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.066977+00:00
generated_at: 2026-05-16T03:24:38.335600+00:00
sec_items: ["1.01", "2.03", "3.01", "9.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-014914
json_url: https://secwatch.observer/filing/0001213900-26-014914.json
markdown_url: https://secwatch.observer/filing/0001213900-26-014914.md
text_url: https://secwatch.observer/filing/0001213900-26-014914.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2033770/000121390026014914/0001213900-26-014914-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2033770/000121390026014914/ea0276026-8k_cidhold.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001213900-26-014914

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.